SG10201801824SA - Agent for reducing catabolism or promoting assimilation of protein - Google Patents
Agent for reducing catabolism or promoting assimilation of proteinInfo
- Publication number
- SG10201801824SA SG10201801824SA SG10201801824SA SG10201801824SA SG10201801824SA SG 10201801824S A SG10201801824S A SG 10201801824SA SG 10201801824S A SG10201801824S A SG 10201801824SA SG 10201801824S A SG10201801824S A SG 10201801824SA SG 10201801824S A SG10201801824S A SG 10201801824SA
- Authority
- SG
- Singapore
- Prior art keywords
- protein
- agent
- reducing catabolism
- promoting assimilation
- assimilation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013190099 | 2013-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201801824SA true SG10201801824SA (en) | 2018-04-27 |
Family
ID=52665755
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201601734XA SG11201601734XA (en) | 2013-09-13 | 2014-09-11 | Agent for reducing catabolism or promoting assimilation of protein |
SG10201801824SA SG10201801824SA (en) | 2013-09-13 | 2014-09-11 | Agent for reducing catabolism or promoting assimilation of protein |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201601734XA SG11201601734XA (en) | 2013-09-13 | 2014-09-11 | Agent for reducing catabolism or promoting assimilation of protein |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP6749097B2 (en) |
CN (1) | CN105530947A (en) |
HK (1) | HK1217181A1 (en) |
SG (2) | SG11201601734XA (en) |
WO (1) | WO2015037655A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201701773A (en) * | 2015-03-20 | 2017-01-16 | 明治股份有限公司 | Renal function-improving agent |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3589807B2 (en) * | 1996-08-27 | 2004-11-17 | 明治乳業株式会社 | Nutritional composition of liquid preparation adapted to each symptom of kidney disease patients |
US7696219B2 (en) * | 2000-09-27 | 2010-04-13 | Everett Laboratories, Inc. | Method and composition for supplementation of nutritional deficiences in renal patients |
JP2008247748A (en) * | 2007-03-29 | 2008-10-16 | En Otsuka Pharmaceutical Co Ltd | Nutritive composition for dialysis patient |
JP5950292B2 (en) * | 2008-12-05 | 2016-07-13 | 味の素株式会社 | Nutritional composition |
JP2012019691A (en) * | 2010-06-17 | 2012-02-02 | Morinaga Milk Ind Co Ltd | Oral nutrient composition for kidney disease patient |
-
2014
- 2014-09-11 WO PCT/JP2014/074051 patent/WO2015037655A1/en active Application Filing
- 2014-09-11 CN CN201480050114.5A patent/CN105530947A/en active Pending
- 2014-09-11 SG SG11201601734XA patent/SG11201601734XA/en unknown
- 2014-09-11 SG SG10201801824SA patent/SG10201801824SA/en unknown
- 2014-09-11 JP JP2015536619A patent/JP6749097B2/en active Active
-
2016
- 2016-05-08 HK HK16105219.6A patent/HK1217181A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1217181A1 (en) | 2016-12-30 |
JP6749097B2 (en) | 2020-09-02 |
WO2015037655A1 (en) | 2015-03-19 |
CN105530947A (en) | 2016-04-27 |
JPWO2015037655A1 (en) | 2017-03-02 |
SG11201601734XA (en) | 2016-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212972A1 (en) | Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases bet--- | |
HK1212207A1 (en) | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | |
HK1216429A1 (en) | Methods for purification of rylsulfatase | |
SG11201603028SA (en) | Purification of proteins | |
IL268868B (en) | Novel method of protein purification | |
HK1220374A1 (en) | Compositions and methods for the treatment of carboxyhemoglobinemia | |
SG11201505220VA (en) | Prevention & treatment of neuropathy | |
IL240763B (en) | Halogenopyrazoles as inhibitors of therombin | |
ZA201603098B (en) | Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseases | |
IL241096B (en) | Method of treatment | |
HK1217181A1 (en) | Agent for reducing catabolism or promoting assimilation of protein | |
EP2852411A4 (en) | Anti-ccl2 antibodies for treatment of scleroderma | |
ZA201601626B (en) | Treatment of gases | |
GB201322778D0 (en) | Method of treatment | |
GB201314882D0 (en) | Method of treatment | |
GB201301722D0 (en) | Quantifcation of bacteria | |
AU2013902513A0 (en) | Method of treatment or prophylaxis |